GlassScriptPhysician profile
Kenneth D Wilgers
NPI 1275506206
$2,734.90
in general payments reported to CMS, 2019-2025
18 companies · $226 in 2025
The $226 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $102 · 2021: $130 · 2022: $621 · 2023: $833 · 2024: $547 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,606.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,380.29 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Novo Nordisk INC | $545.15 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Corium, LLC | $269.87 | 2022-2024 | Azstarys |
| Pfizer INC. | $114.60 | 2019-2024 | |
| Lilly USA, LLC | $69.68 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Antares Pharma, INC. | $61.05 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $47.61 | 2020 | |
| Shire North American Group INC | $38.24 | 2019 | |
| Acella Pharmaceuticals, LLC | $34.51 | 2023-2025 | NP Thyroid 60 |
| Glaxosmithkline, LLC. | $32.04 | 2024-2025 | Arexvy |
| Axsome Therapeutics, INC. | $24.17 | 2025 | Auvelity |
| Abbott Laboratories | $20.61 | 2022 | |
| Exact Sciences Corporation | $19.03 | 2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $17.83 | 2019 | |
| Shield Therapeutics INC | $17.77 | 2023 | Accrufer |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $15.64 | 2022 | |
| Ibsa Pharma INC. | $13.87 | 2022 | |
| Allergan, INC. | $12.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Wilgers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.